Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
暂无分享,去创建一个
[1] G. Grunberger,et al. Hippocampal neuronal apoptosis in type 1 diabetes , 2002, Brain Research.
[2] R. Tanzi,et al. LRP-mediated clearance of Abeta is inhibited by KPI-containing isoforms of APP. , 2005, Current Alzheimer research.
[3] G. Alexander,et al. Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Peters,et al. The selfish brain: competition for energy resources , 2004, Neuroscience & Biobehavioral Reviews.
[5] Ann Marie Schmidt,et al. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. , 2005, Biochimica et biophysica acta.
[6] A. Wada,et al. [Glycogen synthase kinase-3beta]. , 2010, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[7] G. Biessels,et al. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment , 1998, Brain Research.
[8] X. Nogues. Protein kinase C, learning and memory: A circular determinism between physiology and behaviour , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] W. A. Pedersen,et al. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease , 2004, Neurobiology of Disease.
[10] K. Schlett,et al. Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation , 2004, Journal of Biological Chemistry.
[11] H. Klein,et al. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ , 2000, Diabetologia.
[12] J. Wands,et al. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.
[13] A. Roher,et al. RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. , 1998, Restorative neurology and neuroscience.
[14] J. Born,et al. Intranasal Insulin to Improve Memory Function in Humans , 2007, Neuroendocrinology.
[15] S. Pizzo,et al. Coordinate Regulation of the α2-Macroglobulin Signaling Receptor and the Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor by Insulin* , 1999, The Journal of Biological Chemistry.
[16] S. Woods,et al. Central nervous system control of food intake , 2000, Nature.
[17] D. Selkoe,et al. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. , 2003, Annual review of pharmacology and toxicology.
[18] G. Cole,et al. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease , 2007, Experimental Gerontology.
[19] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[20] A. Saltiel,et al. Insulin signaling pathways in time and space. , 2002, Trends in cell biology.
[21] M. Rowan,et al. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. , 2002, Biochemical Society transactions.
[22] S. Woods,et al. Pancreatic signals controlling food intake; insulin, glucagon and amylin , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[23] J. Ryder,et al. Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations. , 2004, Cellular signalling.
[24] C. Kahn,et al. Critical nodes in signalling pathways: insights into insulin action , 2006, Nature Reviews Molecular Cell Biology.
[25] G. Condorelli,et al. Akt Mediates the Cross-Talk Between &bgr;-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes , 2005, Circulation research.
[26] R. Tanzi,et al. GSK3 beta forms a tetrameric complex with endogenous PS1-CTF/NTF and beta-catenin. Effects of the D257/D385A and FAD-linked mutations. , 2000, Annals of the New York Academy of Sciences.
[27] J. Richardson. Cognitive function in diabetes mellitus , 1990, Neuroscience & Biobehavioral Reviews.
[28] Matthias Blüher,et al. Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.
[29] G. Perry,et al. Involvement of maillard reactions in Alzheimer disease , 2009, Neurotoxicity Research.
[30] D. Alkon,et al. Brain Insulin Receptors and Spatial Memory , 1999, The Journal of Biological Chemistry.
[31] Mark von Zastrow,et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD , 2000, Nature Neuroscience.
[32] P. Westermark. Fine structure of islets of Langerhans in insular amyloidosis , 1973, Virchows Archiv A.
[33] Xiongwei Zhu,et al. c‐Jun phosphorylation in Alzheimer disease , 2007, Journal of neuroscience research.
[34] C. Kahn,et al. Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. , 1982, The Journal of biological chemistry.
[35] L. Partridge,et al. Insulin/IGF signalling and ageing: seeing the bigger picture. , 2001, Current opinion in genetics & development.
[36] A. L. Dudley,et al. The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. , 1990, Molecular endocrinology.
[37] R. Turner,et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Finch,et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[40] D. Selkoe,et al. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.
[41] W. Jagust,et al. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. , 1985, The American journal of psychiatry.
[42] J. Hardy,et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.
[43] Barry I. Posner,et al. Insulin receptor internalization and signalling , 1998, Molecular and Cellular Biochemistry.
[44] E. Feskens,et al. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men , 1995, Diabetologia.
[45] P. Francis,et al. Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors , 2008, Neurobiology of Aging.
[46] Xi Chen,et al. RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice , 2004, The EMBO journal.
[47] T. Soderling,et al. Regulation of brain Ca2+/calmodulin-dependent protein kinase II. , 1990, Advances in second messenger and phosphoprotein research.
[48] G. Shulman,et al. On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .
[49] D. Selkoe,et al. Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway* , 2007, Journal of Biological Chemistry.
[50] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[51] H. Orr,et al. The GSK3β signaling cascade and neurodegenerative disease , 2002, Current Opinion in Neurobiology.
[52] L. Mucke,et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease , 1997, Brain Research Reviews.
[53] B. Hyman,et al. The Intracellular Domain of the Low Density Lipoprotein Receptor-related Protein Modulates Transactivation Mediated by Amyloid Precursor Protein and Fe65* , 2003, Journal of Biological Chemistry.
[54] S. Woods,et al. The central nervous system, pancreatic hormones, feeding, and obesity. , 1978, Advances in metabolic disorders.
[55] E. Zee,et al. Historical review of research on protein kinase C in learning and memory , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[56] Hollis T. Cline,et al. Insulin Receptor Signaling Regulates Synapse Number, Dendritic Plasticity, and Circuit Function In Vivo , 2008, Neuron.
[57] W. Rutter,et al. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Morris,et al. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia , 1993, Diabetologia.
[59] S. Kuwajima,et al. Immunochemical Detection of Advanced Glycation End Products in Renal Cortex From STZ-Induced Diabetic Rat , 1993, Diabetes.
[60] R. Cappai,et al. Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth , 2008, Journal of Pathology.
[61] O. Khorkova,et al. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[62] K. Isobe,et al. Amyloid-β peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway , 2006, Neuroscience Research.
[63] G. Dohm,et al. Increased protein kinase C theta in skeletal muscle of diabetic patients. , 2001, Metabolism: clinical and experimental.
[64] S. Xiao,et al. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. , 1996, The Journal of clinical investigation.
[65] E. Van Obberghen,et al. Phosphorylation of Insulin Receptor Substrate-1 on Multiple Serine Residues, 612, 632, 662, and 731, Modulates Insulin Action (*) , 1996, The Journal of Biological Chemistry.
[66] H. Tanila,et al. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice , 2007, Brain Research.
[67] K. Heidenreich,et al. cDNA sequence analysis of the human brain insulin receptor. , 1995, Biochemical and biophysical research communications.
[68] Patrick R Hof,et al. Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[69] A. Turner,et al. Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors. , 1982, The Biochemical journal.
[70] R. Hawkins,et al. Long-Term Depression: A Learning-Related Type of Synaptic Plasticity in the Mammalian Central Nervous System , 1995, Reviews in the neurosciences.
[71] J. Pettegrew,et al. Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study , 1994, Neurobiology of Aging.
[72] J. Olefsky,et al. A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. , 1995, Endocrinology.
[73] G. Siest,et al. Increased protein glycation in cerebrospinal fluid of Alzheimer’s disease 2 2 Abbreviations: AD, Alzheimer’s disease; AGEs, advanced glycation end products; apo, apolipoprotein; BSA, bovine serum albumin; CSF, cerebrospinal fluid; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate buffe , 2001, Neurobiology of Aging.
[74] J. Pessin,et al. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways , 2002, Diabetologia.
[75] A. Artola,et al. Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner , 2005, Journal of neurochemistry.
[76] M. Mattson,et al. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons , 2008, Nature Neuroscience.
[77] Roger Davis,et al. The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.
[78] D. S. Zahm,et al. Insulin gene expression and insulin synthesis in mammalian neuronal cells. , 1994, The Journal of biological chemistry.
[79] I. Lieberburg,et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.
[80] L. Kappelle,et al. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? , 2005, Biochemical Society transactions.
[81] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[82] U. Aebi,et al. Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation* , 2004, Journal of Biological Chemistry.
[83] R A Roth,et al. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. , 1997, Biochemistry.
[84] Christina A. Wilson,et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides , 2003, Nature.
[85] P. Riederer,et al. Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts , 1998, Journal of Neural Transmission.
[86] C. Östenson,et al. Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task , 2007, Behavioural Brain Research.
[87] W. Grant. Dietary links to Alzheimer's disease: 1999 update. , 1999, Journal of Alzheimer's disease : JAD.
[88] Akihiko Takashima,et al. GSK-3 is essential in the pathogenesis of Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[89] G. Biessels,et al. Place Learning and Hippocampal Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats , 1996, Diabetes.
[90] G. Werther,et al. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. , 1987, Endocrinology.
[91] J. Olefsky,et al. Evidence for recycling of insulin receptors in isolated rat adipocytes. , 1981, The Journal of biological chemistry.
[92] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[93] M. White,et al. IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.
[94] J. Sweatt,et al. Molecular psychology: roles for the ERK MAP kinase cascade in memory. , 2002, Annual review of pharmacology and toxicology.
[95] I. Deary,et al. Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies , 1997, Diabetes Care.
[96] M. Raizada,et al. Insulin Is Released from Rat Brain Neuronal Cells in Culture , 1986, Journal of neurochemistry.
[97] L. Mansi,et al. CORTICAL ABNORMALITIES IN ALZHEIMER'S DISEASE , 1984, Annals of neurology.
[98] O. Khorkova,et al. α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation , 1998 .
[99] A. L. Dudley,et al. Heterogeneity of Messenger RNA That Encodes the Rat Insulin Receptor Is Limited to the Domain of Exon 11: Analysis by RNA Heteroduplex Mapping, Amplification of cDNA, and In Vitro Translation , 1992, Diabetes.
[100] William A Banks,et al. The source of cerebral insulin. , 2004, European journal of pharmacology.
[101] P. Iozzo,et al. Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma , 1996, Diabetologia.
[102] C. Oliveira,et al. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. , 2008, Biochimica et biophysica acta.
[103] Michael P. Mazanetz,et al. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases , 2007, Nature Reviews Drug Discovery.
[104] L Partridge,et al. Separating cause from effect: how does insulin/IGF signalling control lifespan in worms, flies and mice? , 2008, Journal of internal medicine.
[105] S. Woods,et al. Intracerebroventricular insulin enhances memory in a passive-avoidance task , 2000, Physiology & Behavior.
[106] M. Smith,et al. Amyloidosis, advanced glycation end products and Alzheimer disease. , 1995, NeuroReport.
[107] Prashanth Kenchappa,et al. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. , 2004, Journal of neuroscience research.
[108] M. Tatar,et al. A Mutant Drosophila Insulin Receptor Homolog That Extends Life-Span and Impairs Neuroendocrine Function , 2001, Science.
[109] I. Deary,et al. Insulin resistance , 1996 .
[110] M. Mattson. Mitochondrial Regulation of Neuronal Plasticity , 2007, Neurochemical Research.
[111] G. Biessels,et al. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats , 1999, Diabetologia.
[112] P. Greengard,et al. Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling , 2001, The Journal of Neuroscience.
[113] F. van Leuven,et al. Glycogen synthase kinase‐3β, or a link between amyloid and tau pathology? , 2008, Genes, brain, and behavior.
[114] J. Hardy,et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. , 1996, Nature medicine.
[115] K. Gerozissis. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. , 2008, European journal of pharmacology.
[116] G. Ramakers,et al. Insulin signaling in the central nervous system: Learning to survive , 2006, Progress in Neurobiology.
[117] W. Staines,et al. Immunohistochemical localization and quantification of glucose transporters in the mouse brain , 2002, Neuroscience.
[118] Xiongwei Zhu,et al. Vascular oxidative stress in Alzheimer disease , 2007, Journal of the Neurological Sciences.
[119] J. Born,et al. Central nervous system effects of intranasally administered insulin during euglycemia in men. , 1999, Diabetes.
[120] A. Klip,et al. Regulation of the Na+/K+-ATPase by insulin: Why and how? , 1998, Molecular and Cellular Biochemistry.
[121] A. Sima,et al. Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes , 2007, Diabetes.
[122] K. Jellinger,et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.
[123] D. Beju,et al. Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system , 1996, Brain Research.
[124] D. Selkoe,et al. Degradation of Amyloid -Protein by a Serine Protease--Macroglobulin Complex (*) , 1996, The Journal of Biological Chemistry.
[125] V. P. Knutson. Proteolytic processing of the insulin receptor beta subunit is associated with insulin-induced receptor down-regulation. , 1991, The Journal of biological chemistry.
[126] W. Schafer,et al. The Insulin/PI 3-Kinase Pathway Regulates Salt Chemotaxis Learning in Caenorhabditis elegans , 2006, Neuron.
[127] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[128] Anatol C. Kreitzer,et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.
[129] L. Hansson,et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. , 1998, Hypertension.
[130] E. Bigio,et al. Monoclonal antibodies that target pathological assemblies of Aβ , 2007, Journal of neurochemistry.
[131] P. R. Gilmore,et al. Structural and Functional Characteristics of Insulin Receptors in Rat Neuroblastoma Cells , 1985, Journal of neurochemistry.
[132] M. Owen,et al. Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.
[133] J. Lynch,et al. Molecular structure and function of the glycine receptor chloride channel. , 2004, Physiological reviews.
[134] S. Gandy,et al. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. , 2005, The Journal of clinical investigation.
[135] M. Tabaton,et al. Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.
[136] S. Santi,et al. Hippocampal hypometabolism predicts cognitive decline from normal aging , 2008, Neurobiology of Aging.
[137] L. Hersh,et al. Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.
[138] C. Hoogenraad,et al. Control of Dendritic Arborization by the Phosphoinositide-3′-Kinase–Akt–Mammalian Target of Rapamycin Pathway , 2005, The Journal of Neuroscience.
[139] A. Hofman,et al. Insulin and Cognitive Function in an Elderly Population: The Rotterdam Study , 1997, Diabetes Care.
[140] Koutarou D. Kimura,et al. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. , 2000, Science.
[141] E. Kandel,et al. Molecular biology of learning: modulation of transmitter release. , 1982, Science.
[142] A. Roher,et al. RAGE-AB Interactions in the Pathophysiology of Alzheimer's Disease , 1998 .
[143] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.
[144] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[145] M. Dragunow,et al. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains , 2006, Neuroscience Letters.
[146] J. Wands,et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.
[147] Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.
[148] A. Schmidt,et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. , 1996, Nature.
[149] G. Small,et al. Predictors of cognitive change in middle-aged and older adults with memory loss. , 1995, The American journal of psychiatry.
[150] H. Orr,et al. The GSK3 beta signaling cascade and neurodegenerative disease. , 2002, Current opinion in neurobiology.
[151] K. Ashe. Synaptic Structure and Function in Transgenic APP Mice , 2000, Annals of the New York Academy of Sciences.
[152] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[153] M. Sheng,et al. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization , 2000, Nature Neuroscience.
[154] Mark A. Smith,et al. Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease , 1995, Journal of neurochemistry.
[155] George Perry,et al. Oxidative Stress and Neurodegeneration , 2005, Annals of the New York Academy of Sciences.
[156] C. Kahn,et al. Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[157] B. Orser,et al. Insulin Increases the Potency of Glycine at Ionotropic Glycine Receptors , 2007, Molecular Pharmacology.
[158] P. Hof,et al. Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[159] J. Girard,et al. Regulation of lipogenic enzyme gene expression by nutrients and hormones , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[160] L. Mucke,et al. Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.
[161] C. Bouras,et al. Age-dependent accumulation of advanced glycosylation end products in human neurons , 1995, Neurobiology of Aging.
[162] Mark A. Smith,et al. Early AGEing and Alzheimer's , 1995, Nature.
[163] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[164] M. Czech. The nature and regulation of the insulin receptor: structure and function. , 1985, Annual review of physiology.
[165] Y. Wang. Probing the role of AMPAR endocytosis and long‐term depression in behavioural sensitization: relevance to treatment of brain disorders, including drug addiction , 2008, British journal of pharmacology.
[166] Michela Gallagher,et al. A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.
[167] R. M. Shepherd,et al. Hyperinsulinism in infancy: from basic science to clinical disease. , 2004, Physiological reviews.
[168] G. Bell. Molecular Defects in Diabetes Mellitus , 1991, Diabetes.
[169] Mark A. Smith,et al. Quantitative solubilization and analysis of insoluble paired helical filaments from alzheimer disease , 1996, Brain Research.
[170] G. Schellenberg,et al. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease , 1998, Neurology.
[171] D. Leroith,et al. Insulin and IGF-I stimulate phosphorylation of their respective receptors in intact neuronal and glial cells in primary culture , 2008, Journal of Molecular Neuroscience.
[172] Ronald C Petersen,et al. Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.
[173] D. Porte,et al. Localization of insulin receptor mRNA in rat brain by in situ hybridization. , 1990, Endocrinology.
[174] B. Hazenberg. Amyloidosis , 1933, The Indian medical gazette.
[175] R. Nicoll,et al. AMPA Receptor Trafficking at Excitatory Synapses , 2003, Neuron.
[176] C. Betsholtz,et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[177] Khan Ah,et al. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. , 2002 .
[178] D. W. Hayden,et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[179] L. Orci,et al. Redistribution of 125I-Insulin on the Surface of Rat Hepatocytes as a Function of Dissociation Time , 1985, Diabetes.
[180] R. Tanzi,et al. GSK3β Forms a Tetrameric Complex with Endogenous PS1‐CTF/NTF and β‐Catenin: Effects of the D257/D385A and FAD‐linked Mutations , 2000 .
[181] S. Hoyer. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update , 2000, Experimental Gerontology.
[182] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[183] C. Messier. Diabetes, Alzheimer's disease and apolipoprotein genotype , 2003, Experimental Gerontology.
[184] W. Singer,et al. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation , 1993, Trends in Neurosciences.
[185] D. Singer,et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. , 1984, The American journal of medicine.
[186] R. Ravid,et al. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology , 2005, Journal of neurochemistry.
[187] J. Thome,et al. Advanced glycation endproducts in ageing and Alzheimer's disease , 1997, Brain Research Reviews.
[188] Jacob Raber,et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[189] J. Thijssen,et al. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model , 1999, Diabetologia.
[190] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[191] W. Ju,et al. Intracellular trafficking of AMPA receptors in synaptic plasticity , 2000, Cellular and Molecular Life Sciences CMLS.
[192] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.
[193] S. Estus,et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.
[194] P. Lansbury,et al. The C‐Terminus of the β Protein is Critical in Amyloidogenesis a , 1993 .
[195] Alcino J. Silva,et al. Molecular mechanisms of synaptic plasticity and memory , 1999, Current Opinion in Neurobiology.
[196] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[197] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[198] S. Kuwajima,et al. Immunochemical Detection of Advanced Glycation End Products in Lens Crystallins From Streptozocin-Induced Diabetic Rat , 1993, Diabetes.
[199] J. W. Kelly. The environmental dependency of protein folding best explains prion and amyloid diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[200] M. Matsumoto,et al. Rage: A Novel Cellular Receptor for Advanced Glycation End Products , 1996, Diabetes.
[201] J. Kusari,et al. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction , 1998, Molecular and Cellular Biochemistry.
[202] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[203] S. Raghavachari,et al. A Unified Model of the Presynaptic and Postsynaptic Changes During LTP at CA1 Synapses , 2006, Science's STKE.
[204] John E. Lisman,et al. The sequence of events that underlie quantal transmission at central glutamatergic synapses , 2007, Nature Reviews Neuroscience.
[205] S. Woods,et al. Food intake and the regulation of body weight. , 2000, Annual review of psychology.
[206] J. Olefsky,et al. Stressed out about obesity and insulin resistance , 2006, Nature Medicine.
[207] T. Hunter,et al. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.
[208] Zhen Yan,et al. Muscarinic Potentiation of GABAA Receptor Currents Is Gated by Insulin Signaling in the Prefrontal Cortex , 2003, The Journal of Neuroscience.
[209] M. Folstein,et al. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis , 2006, Neurobiology of Aging.
[210] E. Gazit,et al. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. , 2003, Biochemistry.
[211] Ming Tong,et al. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[212] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[213] Kenneth H. Johnson,et al. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species , 1989, FEBS letters.
[214] K. Davis,et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.
[215] R. Tian. Another role for the celebrity: Akt and insulin resistance. , 2005, Circulation research.
[216] C. Kahn,et al. Role for neuronal insulin resistance in neurodegenerative diseases , 2004 .
[217] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[218] C. Finch,et al. Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[219] R. Nicoll,et al. Contribution of cytoskeleton to the internalization of AMPA receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[220] R. Roth,et al. Biochemical mechanisms of insulin resistance. , 1994, Hormone research.
[221] L. Lue,et al. Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism , 2001, Experimental Neurology.
[222] Richard S. J. Frackowiak,et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease , 1995, Neuroscience Letters.
[223] D. Selkoe,et al. Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.
[224] W. K. Cullen,et al. Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization , 2008, The Journal of Neuroscience.
[225] J. Reed,et al. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. , 1991, European journal of biochemistry.
[226] S. Hoyer,et al. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis , 1998, Journal of Neural Transmission.
[227] D. Wied,et al. Memory deficit in rats with hereditary diabetes insipidus , 1975, Brain Research.
[228] S. Frautschy,et al. Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. , 2005, Current drug targets. CNS and neurological disorders.
[229] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[230] M. Smith,et al. Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.
[231] Anubhuti,et al. Role of neuropeptides in appetite regulation and obesity – A review , 2006, Neuropeptides.
[232] C. Almeida,et al. Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease , 2005, Neurobiology of Aging.
[233] L. Lue,et al. Modeling microglial activation in Alzheimer’s disease with human postmortem microglial cultures , 2001, Neurobiology of Aging.
[234] W. Tourtellotte,et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[235] R. Sherwin,et al. Effect of recurrent hypoglycemia on spatial cognition and cognitive metabolism in normal and diabetic rats. , 2004, Diabetes.
[236] S. Lovestone,et al. Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[237] E. Hafen,et al. Extension of Life-Span by Loss of CHICO, a Drosophila Insulin Receptor Substrate Protein , 2001, Science.
[238] G. Cherqui,et al. Protein kinase C and insulin receptor β-subunit serine phosphorylation in cultured foetal rat hepatocytes , 1994, Molecular and Cellular Endocrinology.
[239] M. Rowan,et al. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. , 2005, Biochemical Society transactions.
[240] D. Linden,et al. Expression of Cerebellar Long-Term Depression Requires Postsynaptic Clathrin-Mediated Endocytosis , 2000, Neuron.
[241] M. Haan. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease , 2006, Nature Clinical Practice Neurology.
[242] P. Tun,et al. Cognitive and affective disorders in elderly diabetics. , 1990, Clinics in geriatric medicine.
[243] Rosemary O’Connor,et al. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.
[244] E. D. de Koning,et al. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[245] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[246] X. Chen,et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.
[247] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[248] B. Kagan,et al. Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.
[249] M. de la Luz Sierra,et al. A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. , 1991, The Journal of clinical endocrinology and metabolism.
[250] M. Laakso,et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. , 1993, Hypertension.
[251] D. Selkoe,et al. Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex. , 1996, Journal of Biological Chemistry.
[252] R. Kayed,et al. Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.
[253] 山脇 成人,et al. ストレスによるラット脳内 Calcium/calmodulin dependent protein kinase II の発現量リン酸化およびリン酸化に関する検討 , 2002 .
[254] R. Jope,et al. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.
[255] Linda Partridge,et al. Evidence for lifespan extension and delayed age–related biomarkers in insulin receptor substrate 1 null mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[256] C. Ackerley,et al. Recruitment of functional GABAA receptors to postsynaptic domains by insulin , 1997, Nature.
[257] L. Mucke,et al. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. , 1997, Brain research. Brain research reviews.
[258] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[259] S. Hoyer,et al. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update , 2002, Journal of Neural Transmission.
[260] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[261] A. Williamson,et al. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. , 2006, Diabetes.
[262] R. Roth,et al. Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Function by Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[263] C. Kahn,et al. Molecular determinants of insulin action. , 1993, Hormone research.
[264] M. Mattson,et al. Calcium and neurodegeneration , 2007, Aging cell.
[265] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[266] D L Alkon,et al. Classical conditioning induces long-term translocation of protein kinase C in rabbit hippocampal CA1 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[267] B. Kennedy,et al. Protein tyrosine phosphatase-1B in diabetes. , 2000, Biochemical pharmacology.
[268] D. Coates,et al. The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[269] H. Heinze,et al. Insulin Affects the Neuronal Response in the Medial Temporal Lobe in Humans , 2005, Neuroendocrinology.
[270] R. Friedland,et al. Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. , 2003, Metabolism: clinical and experimental.
[271] J. Kuret,et al. Pseudophosphorylation and Glycation of Tau Protein Enhance but Do Not Trigger Fibrillization in Vitro* , 2004, Journal of Biological Chemistry.
[272] S. Craft,et al. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice , 2006, Experimental Neurology.
[273] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[274] Ralf Langen,et al. Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. , 2006, American journal of physiology. Endocrinology and metabolism.
[275] R. Epand,et al. Protein Kinase C , 1993, British Journal of Cancer.
[276] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[277] G. Hotamisligil. The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .
[278] D. Selkoe,et al. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers , 2006, Annals of neurology.
[279] D. Selkoe,et al. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. , 2000, Biochemistry.
[280] P. Lansbury,et al. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.
[281] A. Peters. The selfish brain: Competition for energy resources , 2011, American journal of human biology : the official journal of the Human Biology Council.
[282] T. Soderling,et al. Excitatory interactions between glutamate receptors and protein kinases. , 1994, Journal of neurobiology.
[283] R. Schliebs,et al. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology , 2003, Journal of Neural Transmission.
[284] M. Reger,et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. , 2008, Neurology.
[285] T. Soderling,et al. Calcium/calmodulin-dependent protein kinase II: role in learning and memory , 1993, Molecular and Cellular Biochemistry.
[286] S. Hoyer. Brain glucose and energy metabolism during normal aging , 1990, Aging.
[287] B. Draznin. Molecular Mechanisms of Insulin Resistance , 2019, Contemporary Endocrinology.
[288] S. Gandy,et al. The role of cerebral amyloid β accumulation in common forms of Alzheimer disease , 2005 .
[289] Richard Barnett. Diabetes , 1904, The Lancet.
[290] Jens C. Brüning,et al. The role of insulin receptor signaling in the brain , 2005, Trends in Endocrinology & Metabolism.
[291] D E Kuhl,et al. Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[292] H. Eichenbaum. Hippocampus Cognitive Processes and Neural Representations that Underlie Declarative Memory , 2004, Neuron.
[293] H. Hammes,et al. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats , 1995, Diabetologia.
[294] O. Arancio,et al. Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction , 2008, The Journal of Neuroscience.
[295] C. Mirkin,et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[296] J. A. Nogueira-Machado,et al. From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients. , 2008, Expert opinion on therapeutic targets.
[297] W. Ju,et al. GABAA receptor-associated phosphoinositide 3-kinase is required for insulin-induced recruitment of postsynaptic GABAA receptors , 2007, Neuropharmacology.
[298] D. Le Roith,et al. Recent advances in our understanding of insulin action and insulin resistance. , 2001, Diabetes care.
[299] A. Hofman,et al. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. , 1997, American journal of epidemiology.
[300] W. Klein,et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[301] Eric M. Reiman,et al. FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice , 2008, International Journal of Developmental Neuroscience.
[302] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[303] Tao Lu,et al. The aging brain. , 2008, Annual review of pathology.
[304] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[305] M. Brownstein,et al. Insulin receptors are widely distributed in the central nervous system of the rat , 1978, Nature.
[306] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[307] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[308] R. Malenka,et al. AMPA receptor trafficking and synaptic plasticity. , 2002, Annual review of neuroscience.
[309] A. Young,et al. Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.
[310] S. Floresco,et al. Disruption of AMPA Receptor Endocytosis Impairs the Extinction, but not Acquisition of Learned Fear , 2008, Neuropsychopharmacology.
[311] D. Accili,et al. Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients , 1990, Diabetes Care.
[312] R. Malinow,et al. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.
[313] A. Shuldiner,et al. Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey. , 1994, The Journal of clinical investigation.
[314] M. Raizada,et al. The cellular and physiological actions of insulin in the central nervous system , 1993, Neurochemistry International.
[315] M. Brownlee,et al. Advanced protein glycosylation in diabetes and aging. , 1995, Annual review of medicine.
[316] Feng Chen,et al. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. , 2004, Current drug targets.
[317] K. Hsu,et al. Insulin rescues amyloid β-induced impairment of hippocampal long-term potentiation , 2009, Neurobiology of Aging.
[318] D. Henze,et al. The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. , 2006, Current topics in medicinal chemistry.
[319] E. Chen-Dodson,et al. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons , 2010, Neurobiology of Aging.
[320] E. Krebs,et al. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[321] M. Andrassy,et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.
[322] Ling Xie,et al. Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor , 2002, The Journal of Neuroscience.
[323] G. Schellenberg,et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. , 2008, Journal of Alzheimer's disease : JAD.
[324] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[325] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[326] S. Yen,et al. An immunochemical study on tau glycation in paired helical filaments , 1999, Brain Research.
[327] Yan Han,et al. Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway. , 2006, Acta biochimica et biophysica Sinica.
[328] S. Craft,et al. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis , 2006, Journal of the Neurological Sciences.
[329] B. Teter,et al. Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention , 2004, The Journal of Neuroscience.
[330] S. Woods,et al. Insulin in the brain. , 1987, Annual review of physiology.
[331] R. Bucala,et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[332] G. Dohm,et al. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. , 2000, Diabetes.
[333] Sanjay Asthana,et al. Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender , 1999, Neuroendocrinology.
[334] G. Bell. Lilly lecture 1990. Molecular defects in diabetes mellitus. , 1991, Diabetes.
[335] M. Mattson,et al. Impact of Energy Intake and Expenditure on Neuronal Plasticity , 2008, NeuroMolecular Medicine.
[336] J. Baynes,et al. Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. , 1992, Archives of biochemistry and biophysics.
[337] M. Reger,et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[338] J. Born,et al. Improving Influence of Insulin on Cognitive Functions in Humans , 2001, Neuroendocrinology.
[339] J. Youngren. Regulation of insulin receptor function , 2007, Cellular and Molecular Life Sciences.
[340] L. Ragolia,et al. Protein phosphatase-1 and insulin action , 1998, Molecular and Cellular Biochemistry.
[341] W. Young. Periventricular hypothalamic cells in the rat brain contain insulin mRNA , 1986, Neuropeptides.
[342] Christina A. Wilson,et al. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. , 2003, Nature.
[343] D. Alkon,et al. Insulin and the insulin receptor in experimental models of learning and memory. , 2004, European journal of pharmacology.
[344] C. Finch,et al. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.
[345] H. Matsumoto,et al. Release of Immunoreactive Insulin from Rat Brain Synaptosomes Under Depolarizing Conditions , 1990, Journal of neurochemistry.
[346] Michael J. Rowan,et al. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition , 2001 .
[347] P C O'Brien,et al. Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study. , 1997, American journal of epidemiology.
[348] G. Collingridge,et al. LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.
[349] G. Bell,et al. Alternative splicing of human insulin receptor messenger RNA. , 1989, Biochemical and biophysical research communications.
[350] Yu Tian Wang,et al. Regulation of AMPA Receptor–Mediated Synaptic Transmission by Clathrin-Dependent Receptor Internalization , 2000, Neuron.
[351] R. Rizza,et al. High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress–Mediated β-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes , 2007, Diabetes.
[352] Simeon I. Taylor,et al. Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.
[353] D. Zheleva,et al. Targeting glycogen synthase kinase-3 in insulin signalling , 2006, Expert opinion on therapeutic targets.
[354] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[355] K. Heidenreich,et al. Structural differences between insulin receptors in the brain and peripheral target tissues. , 1983, The Journal of biological chemistry.
[356] Takashi Morihara,et al. A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.
[357] D. Leroith,et al. Insulin receptors in the brain: Structural and physiological characterization , 1988, Neurochemical Research.
[358] K Gerozissis,et al. Brain insulin and feeding: a bi-directional communication. , 2004, European journal of pharmacology.
[359] Robert P. Friedland,et al. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization , 1985, Neuroscience Letters.
[360] S. Small,et al. Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis , 2006, Neuron.
[361] P. Mehta,et al. Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.
[362] C. Almeida,et al. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. , 2005, Neurobiology of aging.
[363] L. Frölich,et al. A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease , 1999, Annals of the New York Academy of Sciences.
[364] L. Niskanen,et al. Short-Term and Long-Term Memory in Elderly Patients with NIDDM , 1995, Diabetes Care.
[365] Elizabeth R Seaquist,et al. Cognitive Dysfunction and Diabetes Mellitus , 2022 .
[366] Werner A. Scherbaum,et al. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans , 2004, Physiology & Behavior.